Breast cancer and laser therapy
Last updated: 21 Dec 2024
10.21608/lira.2024.357509
breast cancer, Doxorubicin, Laser Therapy
Safaa
Taha
Laser Institute for Research and Applications (LIRA), Beni-Suef University, Beni-Suef 62511, Egypt
Wafaa
Mohamed
R.
Laser Institute for Research and Applications (LIRA), Beni-Suef University, Beni-Suef 62511, Egypt , Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
Mai
Elhemely
A.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
mai.ali@manchester.ac.uk
Ahmed
El-Gendy
O.
Faculty of Pharmacy, Department of Microbiology and Immunology, Beni-Suef University, Beni-Suef 62514, Egypt , Laser Institute for Research and Applications (LIRA), Beni-Suef University, Beni-Suef 62511, Egypt
Tarek
Mohamed
Laser Institute for Research and Applications (LIRA), Beni-Suef University, Beni-Suef 62511, Egypt
tarek_mohamed1969@lira.bsu.edu.eg
1
2
48270
2024-06-01
2024-06-01
2024-06-01
43
66
3009-6359
3009-6472
https://lira.journals.ekb.eg/article_357509.html
https://lira.journals.ekb.eg/service?article_code=357509
357,509
Review article
3,101
Journal
Laser Innovations for Research and Applications
https://lira.journals.ekb.eg/
Breast cancer and laser therapy
Details
Type
Article
Created At
21 Dec 2024